HRC proposal—from the same article: “I'm ready to hold drug companies accountable when they try to put profits ahead of patients, instead of back into research and innovation.” That’s boilerplate, almost vacuous, language. No wonder it’s not having much effect on biotech stocks today. HRC’s full statement today is not much more detailed: https://t.co/3fvHRVOTF6